NL6616277A - - Google Patents

Info

Publication number
NL6616277A
NL6616277A NL6616277A NL6616277A NL6616277A NL 6616277 A NL6616277 A NL 6616277A NL 6616277 A NL6616277 A NL 6616277A NL 6616277 A NL6616277 A NL 6616277A NL 6616277 A NL6616277 A NL 6616277A
Authority
NL
Netherlands
Application number
NL6616277A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6616277A publication Critical patent/NL6616277A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/96Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL6616277A 1965-11-19 1966-11-18 NL6616277A (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1598865A CH474486A (de) 1965-11-19 1965-11-19 Verfahren zur Herstellung neuer Diphenylharnstoffe
CH1409266 1966-09-29

Publications (1)

Publication Number Publication Date
NL6616277A true NL6616277A (https=) 1967-05-22

Family

ID=25713607

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6616277A NL6616277A (https=) 1965-11-19 1966-11-18

Country Status (11)

Country Link
US (2) US3560566A (https=)
AT (1) AT269166B (https=)
BE (1) BE689902A (https=)
BR (1) BR6684680D0 (https=)
CH (1) CH474486A (https=)
DE (1) DE1568349A1 (https=)
DK (1) DK118457B (https=)
FR (3) FR1504097A (https=)
GB (1) GB1142066A (https=)
NL (1) NL6616277A (https=)
SE (1) SE323360B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1311432A (en) * 1971-01-07 1973-03-28 Ici Ltd Guanidine derivatives their preparation and antiviral compositions containing them
DE3360148D1 (en) * 1982-02-10 1985-06-05 Beecham Group Plc Guanidine derivatives
US4971986A (en) * 1988-03-25 1990-11-20 Ciba-Geigy Corporation Arylhydrazones useful as SAMDC inhibitors
US5238941A (en) * 1988-03-25 1993-08-24 Ciba-Geigy Corporation Arylhydrazones and pharmaceutical compositions thereof
US5599984A (en) * 1994-01-21 1997-02-04 The Picower Institute For Medical Research Guanylhydrazones and their use to treat inflammatory conditions
US6008255A (en) * 1994-01-21 1999-12-28 The Picower Institute For Medical Research Guanylhydrazones and their use to treat inflammatory conditions
WO2002000613A2 (en) * 2000-06-27 2002-01-03 Axxima Pharmaceuticals Ag Inhibitors of hepatitis b virus infection
US20050282909A1 (en) * 2003-11-14 2005-12-22 Diks Sander H Guanylhydrazones in methods of treatment or diagnosis as modulators of signal transduction
PT1778265E (pt) * 2004-08-17 2013-08-05 Ferring Bv Compostos, composições e métodos de fabrico e utilização de guanilhidrazona
CA2617150C (en) * 2005-07-29 2016-06-14 Government Of The U.S.A., As Represented By The Secretary, Department Of Health And Human Services Use of chk2 kinase inhibitors for cancer treatment
CA2690410C (en) * 2007-06-12 2015-09-29 Provid Pharmaceuticals, Inc. Kinase inhibitors, compositions thereof, and methods of use therewith
WO2014193969A2 (en) * 2013-05-28 2014-12-04 The Regents Of The University Of California Compounds for the treatment of hypertension and hypertensive end stage renal disease

Also Published As

Publication number Publication date
DK118457B (da) 1970-08-24
GB1142066A (en) 1969-02-05
DE1568349A1 (de) 1970-02-12
US3560566A (en) 1971-02-02
US3560557A (en) 1971-02-02
SE323360B (https=) 1970-05-04
FR6153M (https=) 1968-07-01
CH474486A (de) 1969-06-30
BR6684680D0 (pt) 1973-12-18
FR6139M (https=) 1968-06-24
BE689902A (https=) 1967-05-18
FR1504097A (fr) 1967-12-01
AT269166B (de) 1969-03-10

Similar Documents

Publication Publication Date Title
FR6139M (https=)
BE673702A (https=)
BE674972A (https=)
BE660310A (https=)
BE661667A (https=)
BE661712A (https=)
BE663720A (https=)
BE664900A (https=)
BE665163A (https=)
BE665429A (https=)
BE665442A (https=)
BE666088A (https=)
BE666175A (https=)
BE666392A (https=)
BE666471A (https=)
BE667123A (https=)
BE667307A (https=)
BE667656A (https=)
BE668061A (https=)
BE668163A (https=)
BE668316A (https=)
BE668594A (https=)
BE668951A (https=)
BE669331A (https=)
BE669487A (https=)